Published: July 29, 2021
NEW DELHI - US Secretary of State Antony Blinken said ties between India and the United States would be critical for bringing prosperity to the Indo-Pacific region and that India was a top foreign policy priority against the backdrop of mutual unease over Chinas growing assertiveness.
Published: July 26, 2021
Chinas growing presence in Myanmar, the Rohingya refugees, illegal immigration, and drug trafficking have serious security concerns for north east India, according to Indias Chief of Defence Staff General Bipin Rawat.
Published: July 25, 2021
“I am supremely hopeful and confident about the Rise of New India. I can see that the spirit of India is more resurgent than ever before”, Mukesh Ambani, Chairman, Reliance Industries Limited (RIL) wrote in Times of India.
Published: July 23, 2021
Indias actual death toll from covid-19 could range between 1.3 million to a staggering 5 million, with even the most conservative estimate putting its tally at more than double the U.S., the highest recorded in the world so far.
Published: July 21, 2021
For a century, the Indian Council of Medical Research was a little known government body quietly studying illnesses in New Delhi. But during the pandemic, it has taken on a role akin to Anthony Faucis National Institute of Allergy and Infectious Diseases in the U.S. -- a powerful position thats made it a controversial face of Indias struggles with Covid-19.
Published: July 18, 2021
In the wake of India falling victim to drone attacks recently, the Union Home minister Amit Shah has assured that Defence Research and Development Organisation (DRDO) and other agencies are working together to develop an indigenous counter-drone technology which will be available soon.
Published: July 14, 2021
The Indian Medical Association (IMA) warned on Monday that the third wave of the Covid-19 pandemic is “inevitable” and “imminent” and alerted the state governments against allowing potential “super-spreader” events.
Published: July 09, 2021
The Drugs Controller General of India (DCGI) has granted approval to Sanofi and Glaxo Smith Kline (GSK) to conduct phase-III clinical study, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein Covid-19 vaccine candidate in India, the pharma giants announced on Thursday.